KEY FEATURES
Full Name | Fibroblast Growth Factor 4 |
---|---|
Synonym | HBGF4; HST; HSTF1; KFGF; K-FGF; Heparin Secretory Transforming Protein 1; Kaposi Sarcoma Oncogene; Transforming Protein KS3; FGF-Related Oncogene |
Assay Type | Sandwich |
Reactivity | Mouse |
Range | 15.6-1000pg/mL |
Sensitivity | 6pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Mouse FGF4 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse FGF4. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse FGF4 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse FGF4, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse FGF4. You can calculate the concentration of Mouse FGF4 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse FGF4 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 48.32 | 128.98 | 366.37 | 45.47 | 138.81 | 363.06 |
Standard deviation | 3.19 | 6.41 | 14.76 | 2.59 | 7.82 | 18.55 |
CV(%) | 6.61 | 4.97 | 4.03 | 5.7 | 5.63 | 5.11 |
RECOVERY
The recovery of Mouse FGF4 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 94-108 | 100 |
EDTA plasma (n=8) | 93-105 | 99 |
Cell culture media (n=8) | 95-108 | 100 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse FGF4 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with FGF4 ELISA Kits
FGF2 ELISA Kit | publications with FGF4 and FGF2 |
FGF19 ELISA Kit | publications with FGF4 and FGF19 |
FGF1 ELISA Kit | publications with FGF4 and FGF1 |
KLB ELISA Kit | publications with FGF4 and KLB |
FGF21 ELISA Kit | publications with FGF4 and FGF21 |
FGF4 ELISA Kit | publications with FGF4 and FGF4 |
FGF6 ELISA Kit | publications with FGF4 and FGF6 |
FGF9 ELISA Kit | publications with FGF4 and FGF9 |
FGF3 ELISA Kit | publications with FGF4 and FGF3 |
FGF5 ELISA Kit | publications with FGF4 and FGF5 |
Pathways associated with FGF4 ELISA Kit
Adaptive Immune System Pathway | Adaptive Immune System Pathway |
Constitutive PI3K/AKT Signaling In Cancer Pathway | Constitutive PI3K/AKT Signaling In Cancer Pathway |
DAP12 Interactions Pathway | DAP12 Interactions Pathway |
DAP12 Signaling Pathway | DAP12 Signaling Pathway |
Disease Pathway | Disease Pathway |
Downstream Signal Transduction Pathway | Downstream Signal Transduction Pathway |
Downstream Signaling Events Of B Cell Receptor (BCR) Pathway | Downstream Signaling Events Of B Cell Receptor (BCR) Pathway |
Downstream Signaling Of Activated FGFR Pathway | Downstream Signaling Of Activated FGFR Pathway |
Endocytosis Pathway | Endocytosis Pathway |
Diseases associated with FGF4 ELISA Kit
Breast Neoplasms | publications with FGF4 and Breast Neoplasms |
Liver Diseases | publications with FGF4 and Liver Diseases |
Brain Diseases | publications with FGF4 and Brain Diseases |
Carcinoma, Hepatocellular | publications with FGF4 and Carcinoma, Hepatocellular |
Liver Neoplasms | publications with FGF4 and Liver Neoplasms |
Neoplasms, Experimental | publications with FGF4 and Neoplasms, Experimental |
Disease Models, Animal | publications with FGF4 and Disease Models, Animal |
Lung Neoplasms | publications with FGF4 and Lung Neoplasms |
Lung Diseases | publications with FGF4 and Lung Diseases |
Neoplasm Metastasis | publications with FGF4 and Neoplasm Metastasis |
Organs/Tissues associated with FGF4 ELISA Kit
Liver | publications with FGF4 and Liver |
Muscle | publications with FGF4 and Muscle |
Embryonic Tissue | publications with FGF4 and Embryonic Tissue |
Blood | publications with FGF4 and Blood |
Lung | publications with FGF4 and Lung |
Brain | publications with FGF4 and Brain |
Intestine | publications with FGF4 and Intestine |
Kidney | publications with FGF4 and Kidney |
Nerve | publications with FGF4 and Nerve |
Lymph | publications with FGF4 and Lymph |